Clinical Trials
2 trialsNCT02314481 2026-05-04
DARWINII
University College, London
Phase 2 Completed
NCT02289833 2019-08-07
A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor (HER)2 Immunohistochemistry (IHC)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Hoffmann-La Roche
Phase 2 Completed